Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Upexi, Inc. (UPXI)

0.7593 -0.0606 (-7.39%)
At close: October 30 at 4:00:00 PM EDT
0.7700 +0.0107 (+1.41%)
After hours: October 30 at 7:55:36 PM EDT
Chart Range Bar
Loading chart for UPXI
  • Previous Close 0.8199
  • Open 0.7654
  • Bid 0.7490 x 100
  • Ask 1.3200 x 200
  • Day's Range 0.7317 - 0.7913
  • 52 Week Range 0.5400 - 4.4100
  • Volume 1,468,897
  • Avg. Volume 3,125,346
  • Market Cap (intraday) 66.954M
  • Beta (5Y Monthly) -0.23
  • PE Ratio (TTM) --
  • EPS (TTM) -3.8700
  • Earnings Date (est.) Nov 11, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 2.00
  • Motley Fool Rating Bearish

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

www.upexi.com

10

Full Time Employees

June 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UPXI
54.80%
S&P 500 (^GSPC)
10.73%

1-Year Return

UPXI
82.18%
S&P 500 (^GSPC)
11.11%

3-Year Return

UPXI
96.70%
S&P 500 (^GSPC)
81.91%

5-Year Return

UPXI
99.36%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 3.15M
Earnings --
Profit Margin 0.00%

Q4

FY25

Q1

FY26

Q2

FY26

Q4

FY26

0
2M
4M
6M
8M
0.0%

Analyst Insights

View More

Analyst Price Targets

2.00
2.00 Average
0.7593 Current
2.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/18/2026
Analyst Cantor Fitzgerald
Rating Action Reiterates
Rating Overweight
Price Action Maintains
Price Target 2 -> 2

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -98.16%

  • Return on Equity (ttm)

    -1,356.34%

  • Revenue (ttm)

    25M

  • Net Income Avi to Common (ttm)

    -246.06M

  • Diluted EPS (ttm)

    -3.8700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.78M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -184.96M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: